Dr. Gerald W. Hull III, MD

Dr. Hull practices at Spartanburg Medical Center in Spartanburg, South Carolina, part of Spartanburg Regional Healthcare System.

Dr. Hull's NPI, 1639130628, was assigned on March 29, 2006. Dr. Hull graduated from University of Florida College of Medicine in 1992. Dr. Hull holds South Carolina license 16661.

Dr. Hull's primary practice is Spartanburg Medical Center, at 101 E Wood St, Spartanburg, SC 29303 in Spartanburg County. The practice phone is (864) 560-6554.

Dr. Hull's primary practice is Spartanburg Medical Center in Spartanburg, South Carolina, part of Spartanburg Regional Healthcare System. Dr. Hull is also affiliated with Prisma Health Greenville Memorial Hospital. The medical group on file is Medical Group of the Carolinas - Family Medicine - Converse Heights. Dmand AI also links Dr. Hull to 3 more hospitals, 1 group practice or clinic, 1 ambulatory surgery center and 1 medical group, each named with a free account. Dr. Hull's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hull practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Hull's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Hull is licensed in South Carolina.

CMS data shows 743 Medicare services from Dr. Hull across 18 procedure codes in 2024, for 392 Medicare patients. Medicare paid $93,367 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 392 Medicare patients who saw Dr. Hull in 2024. The largest group is 65 to 74, with 222 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hull's median patient age at 73, with 13% women.

In 2024, Dr. Hull wrote 1,018 Medicare Part D claims for 331 patients. 96% of them were for generic drugs. CMS names the drug for 917 of them, across 14 drugs with 11 or more claims each, at $39,641 in total drug cost. In 2023, CMS named 1,018 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Hull for performance year 2024, reported through an alternative payment model (APM). Dr. Hull accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 22 procedures of prostate resection by Dr. Hull, more than 84% of the clinicians it reports for that procedure.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 246 general payments to Dr. Hull from 49 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Philips Electronics North America Corporation paid the most, $863.

Dr. Hull graduated from University of Florida College of Medicine in 1992.